Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.
Voitl
P
P
Pediatric Intensive Care Unit, Danube Hospital Vienna, Langobardenstr 122, 1220 Vienna, Austria. peter.voitl@smz.magwien.gv.at
Scheibenpflug
C
C
Weber
T
T
Janata
O
O
Rokitansky
A M
AM
D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D004359:Drug Therapy, Combination; D054714:Echinocandins; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D055666:Lipopeptides; D009091:Mucormycosis / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D010455:Peptides; D010456:Peptides, Cyclic; D012233:Rhizopus / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin